Shareholders' Equity	6 Months Ended
Mar. 30, 2019
Equity [Abstract]
Shareholders' Equity	Shareholders’ EquityAs of March 30, 2019, the Company had an authorized program to repurchase up to $100 billion of the Company’s common stock, of which $61.3 billion had been utilized. During the six months ended March 30, 2019, the Company repurchased 164.7 million shares of its common stock for $32.2 billion, including 55.1 million shares initially delivered under a $12.0 billion accelerated share repurchase arrangement dated February 2019. On April 30, 2019, the Company announced the Board of Directors increased the share repurchase program authorization from $100 billion to $175 billion. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Shareholders' Equity

6 Months Ended

Mar. 30, 2019

Shareholders’ EquityAs of March 30, 2019, the Company had an authorized program to repurchase up to $100 billion of the Company’s common stock, of which $61.3 billion had been utilized. During the six months ended March 30, 2019, the Company repurchased 164.7 million shares of its common stock for $32.2 billion, including 55.1 million shares initially delivered under a $12.0 billion accelerated share repurchase arrangement dated February 2019. On April 30, 2019, the Company announced the Board of Directors increased the share repurchase program authorization from $100 billion to $175 billion. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).